Forensic Analysis · Trading Companies & Distributors · as of Sep 25, 2026
Resideo Technologies, Inc. (REZI)
A forensic read on Resideo Technologies, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Grey Zone
Financial health
2.4
Distress distance
Clean
Earnings quality
5
Forensic signals
6.5
P / E (ttm)
-18.1%
ROE
$2.8B
Market cap
1.25%
Dividend yield
10.5%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence, going concern, valuation). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Resideo Technologies, Inc. earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads 2.4, placing it in the Grey zone. 5 forensic signals were flagged in its latest SEC filings, led by shareholder returns — halted.
What the filings flag
stopped
FY2024→FY2025
Shareholder returns — halted.Capital returns have STOPPED — $1M of buybacks + dividends in FY2024, but ~$0 in FY2025. A halt usually means the company is conserving cash.
+16.6%
FY2024→FY2025
Accruals ratio (% of NOA).Net operating assets grew +16.6% relative to their own average in FY2025 — scaled by NOA itself, not by total assets, which is what the Forensic Screens card's own accrual row divides by. Accruals are building faster than is comfortable — part of profit is sitting in the balance sheet rather than turning to cash. The build is led by inventory up +9% against +9% in cost of sales. A cash-flow measure on the same base agrees: reported earnings ran ahead of operating cash by 12% of net operating assets, against an accruals ratio of 16.6%. The two are computed differently: the accruals ratio is the change in net operating assets over average net operating assets, while the cash-flow figure is net income less operating cash flow over that same average.
90d
FY2024→FY2025
Inventory days.Days inventory outstanding moved from 82 to 90 FY2024→FY2025 (against cost of goods sold; inventory +9% vs +9% in cost of sales). Inventory is building a little faster than sales — watch for markdowns.
7.9%
FY2025
Return on invested capital.Return on invested capital is 7.9% in the latest fiscal year, against 8.2% in FY2023, having run between 5.9% and 8.2% across FY2023–FY2025 with no direction held. After-tax operating profit was $367M in FY2023 and $480M in FY2025, with operating income at 8.8% of revenue in FY2023, 7.7% in FY2024 and 8.1% in FY2025. The capital base behind it grew +34% across FY2023–FY2025, from $4.5B to $6.0B, while the return fell 0.3 points, so the dollars added over that window earned less than the 8.2% the older base was already earning.
Key fundamentals
Latest Revenue$7.47B
Revenue Growth YoY+10.5%
Revenue CAGR (2yr)+9.4%
Net Margin-7.1%
Free Cash Flow-$1.25B
Return on Equity-18.1%
Debt / Equity1.09x
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Resideo Technologies, Inc.'s actual 10-K/10-Q/8-K filings?
Data from SEC EDGAR public filings · metrics as of Sep 25, 2026. Forensic signals flag probability, not certainty.
Resideo Technologies, Inc. (REZI) Stock — Forensic Analysis, Red Flags & Rating | Stockonomy · Stockonomy
+0.3%/yr
FY2023–FY2025
Share count.Diluted share count changed +1% over the last 2 years to FY2025 (+0.3%/yr). Roughly flat — the count is neither shrinking nor growing meaningfully. Per-share value isn't being meaningfully helped or hurt by the count.